Zobrazeno 1 - 10 of 111 pro vyhledávání: '"JC Cameron"'
2
Severe complications of chickenpox in hospitalised children in the UK and Ireland
Autor: Robert Booy, G Allan, Adam Finn, F Johnston, JC Cameron, Paul T. Heath
Publikováno v: University of Bristol-PURE
To estimate the annual incidence of hospitalisations due to severe complications of varicella, describe the complications and estimate annual mortality.Active surveillance throughout the UK and Ireland for 13 months by paediatricians notifying cases
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4de3126ced397bd6418d14f2f316c8ae
https://doi.org/10.1136/adc.2007.123232
Zobrazit plný text záznamu
4
Intussusception in the first year of life: a UK national surveillance study
Autor: JC Cameron, HE Bashir, L. Samad, Alastair G. Sutcliffe, Sean Marven, B. Taylor, Richard Lynn
Publikováno v: Archives of Disease in Childhood. 95:A1.2-A1
Background Rotavirus infection is the commonest cause of severe childhood diarrhoea. This remains a major cause of death and illness but can be substantially reduced by vaccination. Initial attempts at rotavirus vaccination seemed to increase the ris
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5f00069e64d9ba5e96398991105c4839
https://doi.org/10.1136/adc.2010.186338.2
Zobrazit plný text záznamu
5
Chronic anterior cruciate ligament deficiency. Long-term results of MacIntosh's lateral substitution reconstruction
Autor: JD Amirault, P. H. Marks, JC Cameron, DL MacIntosh
Publikováno v: The Journal of Bone and Joint Surgery. British volume. :622-624
The lateral substitution reconstruction operation described by MacIntosh has been evaluated in 27 patients with chronic anterior cruciate ligament deficiency of the knee. The results, at an average of 11.3 years after operation, have been assessed by
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::715bfcdf7f32b314e40d994894fa283b
https://doi.org/10.1302/0301-620x.70b4.3403611
Zobrazit plný text záznamu
6
Akademický článek
Association between antibody responses post-vaccination and severe COVID-19 outcomes in Scotland.
Autor: Macdonald C; Usher Institute, University of Edinburgh, Teviot Pl, EH8 9AG, Edinburgh, UK. calum.macdonald@hdruk.ac.uk.; Health Data Research UK, Gibbs Building, 215 Euston Road, NW1 2BE, London, UK. calum.macdonald@hdruk.ac.uk., Palmateer N; School of Health and Life Sciences, Glasgow Caledonian University, Cowcaddens, Road, Glasgow, G4 0BA, UK. norah.palmateer@phs.scot.; Public Health Scotland, Meridian Court, 5 Cadogan Street, G2 6QE, Glasgow, UK. norah.palmateer@phs.scot., McAuley A; School of Health and Life Sciences, Glasgow Caledonian University, Cowcaddens, Road, Glasgow, G4 0BA, UK.; Public Health Scotland, Meridian Court, 5 Cadogan Street, G2 6QE, Glasgow, UK., Lindsay L; Public Health Scotland, Meridian Court, 5 Cadogan Street, G2 6QE, Glasgow, UK., Hasan T; Public Health Scotland, Meridian Court, 5 Cadogan Street, G2 6QE, Glasgow, UK., Hameed SS; Public Health Scotland, Meridian Court, 5 Cadogan Street, G2 6QE, Glasgow, UK., Hall E; Public Health Scotland, Meridian Court, 5 Cadogan Street, G2 6QE, Glasgow, UK., Jeffrey K; Usher Institute, University of Edinburgh, Teviot Pl, EH8 9AG, Edinburgh, UK., Grange Z; Public Health Scotland, Meridian Court, 5 Cadogan Street, G2 6QE, Glasgow, UK., Gousias P; Public Health Scotland, Meridian Court, 5 Cadogan Street, G2 6QE, Glasgow, UK., Mavin S; Scottish Microbiology Reference Laboratory, Raigmore Hospital, Old Perth Road, Inverness, IV2 3UJ, UK., Jarvis L; Scottish National Blood Transfusion Service, Jack Copland Centre, 52 Research Avenue North, EH14 4BE, Edinburgh, UK., Cameron JC; Public Health Scotland, Meridian Court, 5 Cadogan Street, G2 6QE, Glasgow, UK., Daines L; Usher Institute, University of Edinburgh, Teviot Pl, EH8 9AG, Edinburgh, UK., Tibble H; Usher Institute, University of Edinburgh, Teviot Pl, EH8 9AG, Edinburgh, UK., Simpson CR; School of Health, Wellington Faculty of Health, Victoria University of Wellington, PO Box 600, Wellington, 6140, Wellington, New Zealand., McCowan C; School of Medicine, University of St Andrews, North Haugh, St Andrews, KY16 9TF, UK., Katikireddi SV; Public Health Scotland, Meridian Court, 5 Cadogan Street, G2 6QE, Glasgow, UK.; MRC/CSO Social & Public Health Sciences Unit, University of Glasgow Berkeley Square, 99 Berkeley St., G3 7HR, Glasgow, UK., Rudan I; Usher Institute, University of Edinburgh, Teviot Pl, EH8 9AG, Edinburgh, UK., Fagbamigbe AF; Institute of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill Rd, AB25 2ZD, Aberdeen, UK., Ritchie L; Centre of Academic Primary Care, University of Aberdeen, Polwarth Building, Foresterhill Rd, AB25 2ZD, Aberdeen, UK., Swallow B; School of Mathematics and Statistics, University of St Andrews, KY16 9SS, St Andrews, UK., Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Cancer Sciences Building, Edgbaston, B15 2TT, Birmingham, UK., Robertson C; Public Health Scotland, Meridian Court, 5 Cadogan Street, G2 6QE, Glasgow, UK.; Department of Mathematics and Statistics, University of Strathclyde, Richmond Street Glasgow, G1 1XH, Glasgow, UK., Sheikh A; Usher Institute, University of Edinburgh, Teviot Pl, EH8 9AG, Edinburgh, UK.; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, Oxford, UK., Murray J; Public Health Scotland, Meridian Court, 5 Cadogan Street, G2 6QE, Glasgow, UK.; School of Medicine, University of St Andrews, North Haugh, St Andrews, KY16 9TF, UK.
Publikováno v: NPJ vaccines [NPJ Vaccines] 2024 Jun 14; Vol. 9 (1), pp. 107. Date of Electronic Publication: 2024 Jun 14.
Zobrazit plný text záznamu
7
Akademický článek
COVID-19 vaccine safety in Scotland - background rates of adverse events of special interest.
Autor: Cullen LA; Public Health Scotland, Glasgow, Edinburgh, UK. Electronic address: lucy.cullen@phs.scot., Grange Z; Public Health Scotland, Glasgow, Edinburgh, UK. Electronic address: zoe.grange@phs.scot., Antal K; Public Health Scotland, Glasgow, Edinburgh, UK. Electronic address: karen.antal3@phs.scot., Waugh L; Public Health Scotland, Glasgow, Edinburgh, UK. Electronic address: lynsey.waugh@phs.scot., Alsina MS; Public Health Scotland, Glasgow, Edinburgh, UK. Electronic address: Marianne.simduwaalsina@phs.scot., Gibbons CL; Public Health Scotland, Glasgow, Edinburgh, UK. Electronic address: Cheryl.gibbons@phs.scot., MacDonald LE; Public Health Scotland, Glasgow, Edinburgh, UK. Electronic address: laura.macdonald4@phs.scot., Robertson C; University of Strathclyde and Public Health Scotland, Glasgow, UK. Electronic address: chris.robertson@strath.ac.uk., Cameron JC; Public Health Scotland, Glasgow, Edinburgh, UK. Electronic address: claire.cameron2@phs.scot., Stockton D; Public Health Scotland, Glasgow, Edinburgh, UK. Electronic address: diane.stockton2@phs.scot., O'Leary MC; Public Health Scotland, Glasgow, Edinburgh, UK. Electronic address: Maureen.Oleary@phs.scot.
Publikováno v: Public health [Public Health] 2023 Nov; Vol. 224, pp. 1-7. Date of Electronic Publication: 2023 Sep 07.
Zobrazit plný text záznamu
8
Akademický článek
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.
Autor: Kelly E; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Greenland M; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., de Whalley PCS; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Aley PK; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Plested EL; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Singh N; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Koleva S; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Tonner S; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Macaulay GC; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Read RC; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Ramsay M; Immunisation and Countermeasures Division, National Infection Service, Public Health England, London, UK., Cameron JC; Health Protection Scotland, Glasgow, UK., Turner DPJ; University of Nottingham, UK; Nottingham University Hospitals NHS Trust, Nottingham, UK., Heath PT; Vaccine Institute, St. George's, University of London and St. George's University Hospitals NHS Trust, London, UK., Bernatoniene J; Paediatric Infectious Disease and Immunology Department, Bristol Royal Hospital for Children, University Hospitals Bristol and Weston NHS Foundation Trust, University of Bristol, UK., Connor P; Noah's Ark Children's Hospital for Wales, University Hospital of Wales, Cardiff, UK., Cathie K; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Banerjee I; Royal Manchester Children's Hospital, Manchester University Hospitals Foundation Trust, UK., Cantrell L; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Mujadidi YF; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Belhadef HT; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Clutterbuck EA; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Anslow R; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Valliji Z; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., James T; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Hallis B; UK Health Security Agency, Porton Down, Salisbury, UK., Otter AD; UK Health Security Agency, Porton Down, Salisbury, UK., Lambe T; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK; Chinese Academy of Medical Science (CAMS) Oxford Institute, University of Oxford, Oxford, UK., Nguyen-Van-Tam JS; Population and Lifespan Health, University of Nottingham, Nottingham, UK., Minassian AM; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK; Department of Biochemistry, University of Oxford, UK. Electronic address: angela.minassian@bioch.ox.ac.uk., Liu X; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK., Snape MD; Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Department of Paediatrics, University of Oxford, Oxford, UK.
Publikováno v: The Journal of infection [J Infect] 2023 Sep; Vol. 87 (3), pp. 230-241. Date of Electronic Publication: 2023 Jun 17.
Zobrazit plný text záznamu
9
Akademický článek
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
Autor: Shaw RH; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: robert.shaw@paediatrics.ox.ac.uk., Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Stuart ASV; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Andrews NJ; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Cameron JC; Public Health Scotland, Glasgow, Scotland, UK., Charlton S; UK Health Security Agency, Porton Down, Salisbury, UK., Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Collins AM; Liverpool School of Tropical Medicine, Liverpool, UK., Darton T; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, UK., Dinesh T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Duncan CJA; The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK; Translational and Clinical Research Institute, Newcastle University, UK., Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Ferreira DM; Liverpool School of Tropical Medicine, Liverpool, UK., Finn A; Schools of Population Health Sciences and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Goodman AL; Department of Infection & NIHR BRC, Guy's and St Thomas' NHS Foundation Trust, UK; MRC Clinical Trials Unit, University College London, UK., Green CA; NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; School of Chemical Engineering, University of Birmingham, UK., Hallis B; UK Health Security Agency, Porton Down, Salisbury, UK., Heath PT; The Vaccine Institute, St. George's University of London, London, UK., Hill H; Liverpool School of Tropical Medicine, Liverpool, UK., Lambe T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK., Libri V; NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK., Lillie PJ; Infection Research Group, Hull University Teaching Hospitals NHS Trust, Hull, UK., Morey E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Payne R; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, UK., Plested EL; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Provstgaard-Morys S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Ramsay M; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Read RC; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Screaton GR; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Singh N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Turner DPJ; University of Nottingham, Nottingham, UK; Nottingham University Hospitals NHS Trust, Nottingham, UK., Turner PJ; National Heart & Lung Institute, Imperial College London, London, UK., White R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Nguyen-Van-Tam JS; Unit of Lifespan and Population Health, University of Nottingham School of Medicine, Nottingham, UK., Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Snape MD; Oxford NIHR - Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publikováno v: The Journal of infection [J Infect] 2023 Jun; Vol. 86 (6), pp. 574-583. Date of Electronic Publication: 2023 Apr 06.
Zobrazit plný text záznamu
10
Akademický článek
Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022.
Autor: Rodrigues CMC; Department of Biology, University of Oxford, Oxford, United Kingdom.; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Paediatrics, Imperial College Healthcare NHS Trust, London, United Kingdom., MacDonald L; Public Health Scotland, Glasgow/Edinburgh, United Kingdom., Ure R; Bacterial Respiratory Infection Service, Scottish Microbiology Reference Laboratory, Glasgow Royal Infirmary, Glasgow, United Kingdom., Smith A; Bacterial Respiratory Infection Service, Scottish Microbiology Reference Laboratory, Glasgow Royal Infirmary, Glasgow, United Kingdom.; College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital & School, University of Glasgow, Glasgow, United Kingdom., Cameron JC; Public Health Scotland, Glasgow/Edinburgh, United Kingdom., Maiden MCJ; Department of Biology, University of Oxford, Oxford, United Kingdom.
Publikováno v: MBio [mBio] 2023 Apr 25; Vol. 14 (2), pp. e0049923. Date of Electronic Publication: 2023 Apr 10.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje